Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2022 | Story Edzani Nephalela and Coreen Steenkamp | Photo Francois van Vuuren
Academic Leadership Programme
The new cohort of the Academic Leadership Programme.

Educational leaders serve a significant administrative, management, and leadership function in higher education. A departmental chair’s role differs fundamentally from other leadership contexts, based on the momentous transition from being an academic by profession to providing leadership at departmental level.
The Academic Leadership Programme (APL) was launched by the University of the Free State (UFS) Centre for Teaching and Learning (CTL) to equip academics for various managerial positions. Faculty deans propose candidates for this programme; the second cohort has been chosen as the first is nearing completion. 
The first workshop commenced with an engagement with the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen, and the Vice-Rector: Academic, Dr Engela van Staden, who both shared strategic academic leadership perspectives during the orientation and welcoming of the APL. 
Such reflections highlighted the expectations of being an educator, the complexity, and the critical role of departmental chairs within higher education institutions. Academic leaders are thus expected to establish firm leadership within their departments, facilitate intellectual development, manage administrative duties, and strive toward resilient learning and teaching environments. 
“The position of departmental chairs remains critical for any higher education institution, as they provide leadership in advancing the discipline, teaching students, producing quality graduates, and serving the professional community,” said Prof Francois Strydom, Senior Director: Centre for Teaching and Learning.
Research confirms that most academics succeed in these roles without formal leadership training, yet the expectation of developing or having certain leadership qualities or management competencies must fulfil the various functions of such a position. 


News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept